For example, in patients with non-small cell lung cancers (NSCLCs), PD-L1 expression was associated with improved overall survival independent of age and stage of disease[17] and also associated with improved overall survival in early stage patients[18]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.